Clinical Trials Logo

Blood Loss, Postoperative clinical trials

View clinical trials related to Blood Loss, Postoperative.

Filter by:

NCT ID: NCT06189911 Completed - Clinical trials for Blood Loss, Postoperative

Perioperative Blood Transfusion in Open Liver Resection

Start date: January 1, 2006
Phase:
Study type: Observational

This observational study is specifically designed to identify the pre-operative risk factors that significantly contribute to perioperative packed red cell transfusions in open liver resection procedures. The main question it aims to answer are: 1. What are the risk factors of peri-operative blood transfusion in open liver resection procedures 2. What are the difference outcomes between patients who receive blood transfusion and the other group. Researcher will compare perioperative factor and post operative outcomes between transfused and non-transfused group

NCT ID: NCT06060327 Not yet recruiting - Clinical trials for Cesarean Section Complications

Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

The study will include 444 pregnant patients undergoing cesarean section in Kasr Al Aini. Following a proper medical history taking, examination will be done, investigations including laboratory tests and obstetric ultrasound will be done. Then, the patients will be divided into 4 groups, receiving Oxytocin only (Group 1), Oxytocin + Tranexamic acid (Group 2), Oxtytocin and Misoprostol (Group 3) or Oxytocin and Carbetocin (Group 4) followed by collection of necessary data.

NCT ID: NCT06049160 Recruiting - Clinical trials for Blood Loss, Surgical

Comparative Study Between Preoperative and Postoperative Rectal Misoprostol

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

Cesarean delivery (CD) is the most common major surgical procedure undergone by women around the world. Over the past two decades, there has been a witnessed increase in rates of caesarean deliveries, which continues to rise, achieving 30% in resource-rich countries and exceeding 60% in resource-limited countries. According to a Lancet report 2014, Egypt is one of the countries with the highest rates of caesarean delivery, in which the rate had reached 55.5%. The rate is almost double to three times the ideal rate of 10%-15%

NCT ID: NCT05316649 Recruiting - Clinical trials for Postoperative Complications

Blood Loss Quantification During Major Abdominal Surgery

Start date: May 1, 2021
Phase:
Study type: Observational

Blood loss quantification during surgery remains unreliable and inaccurate. The purpose of the study is compare several methods of blood loss quantification in real surgical settings and to analyze the effect of blood loss on postoperative complications.

NCT ID: NCT05273632 Completed - Clinical trials for Blood Loss, Surgical

Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)

Start date: March 20, 2022
Phase: N/A
Study type: Interventional

Comparison Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate Versus Normal Saline as Pre-operative Administration.

NCT ID: NCT05204056 Completed - Pain, Postoperative Clinical Trials

Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty

Start date: March 2, 2018
Phase: N/A
Study type: Interventional

Sixty patients undergoing TKA were divided into three groups, then three different intro-operative articular cavity perfusion treatment was given according to the randomized, double-blind and controlled rule. One way ANOVA analysis on visual analogue scale (VAS) score, functional recovery, drainage, and edema of the affected limb were performed to assess the efficiency of the treatment in the following three days after the operation.

NCT ID: NCT05093504 Terminated - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

STAR-D
Start date: December 27, 2021
Phase: N/A
Study type: Interventional

Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

NCT ID: NCT05077124 Recruiting - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal (STAR) Registry

Start date: September 30, 2021
Phase:
Study type: Observational

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

NCT ID: NCT04976530 Completed - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

STAR-T
Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).

NCT ID: NCT04656067 Completed - Clinical trials for Blood Loss, Surgical

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate

Start date: April 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate, Pre-operative Administration.